PLSE vs TFC · rev $835.0K vs rev $11.82B
Pulse Biosciences Inc (PLSE) versus TFC (TFC) — a side-by-side from cached financials, not a winner call.
Pulse Biosciences Inc (PLSE) is a medical instruments & supplies company listed on US.
TFC (TFC) common stock.
Latest reported PLSE revenue for 2026-06-30 was $835.0K. Net income was -$43.2M. PLSE currently screens at market cap $1.03B.
Latest reported TFC revenue for 2026-06-30 was $11.82B. Net income was $3.03B. TFC currently screens at market cap $0.
PLSE currently screens at market cap $1.03B. TFC currently screens at market cap $0.
Not investment advice. Open the PLSE and TFC stock pages for the full models.
Not investment advice.